Sarepta Therapeutics (SRPT) FCF Margin (2010 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly FCF Margin of 28.02% for Q1 2026, up 44230.0% year-over-year from N/an in Q1 2025, and down 197.25% quarter-over-quarter from 28.81% in Q4 2025.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) FCF Margin (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' FCF Margin history runs 15 years deep, the most recent figure standing at 28.02% for Q1 2026.
- In Q1 2026, FCF Margin rose 44230.0% year-over-year to 28.02%; the TTM figure through Mar 2026 stood at 5.26% (up 4813.0% YoY), while the FY2025 annual figure was 16.49%, up 153.0% from the prior year.
- FCF Margin for Q1 2026 stood at 28.02%, down from 28.81% in the prior quarter.
- The five-year high for FCF Margin was 37.56% in Q2 2025, with the low at 470.32% in Q1 2025.
- The 5-year median for FCF Margin is 28.02% (2026), against an average of 50.83%.
- The sharpest annual moves came in 2022 and 2025: FCF Margin jumped 56199 bps in 2022, then slumped 40392 bps in 2025.
- Sarepta Therapeutics' FCF Margin stood at 11.58% in 2022, then jumped by 41 bps to 6.84% in 2023, then soared by 220 bps to 8.2% in 2024, then jumped by 252 bps to 28.81% in 2025, then slumped by 197 bps to 28.02% in 2026.
- Business Quant data shows SRPT's FCF Margin at 28.02% in Q1 2026, 28.81% in Q4 2025, and 9.39% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Sarepta Therapeutics | 2.36 Bn | 1.57 Bn | 251.87 Mn | 48.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.98% |
| Mar 31, 2026 | -28.02% |
| Dec 31, 2025 | 28.81% |
| Sep 30, 2025 | -9.39% |
| Jun 30, 2025 | 37.56% |
| Mar 31, 2025 | -84.19% |
| Dec 31, 2024 | 8.20% |
| Sep 30, 2024 | -23.11% |
| Jun 30, 2024 | -3.92% |
| Mar 31, 2024 | -66.40% |
| Dec 31, 2023 | -18.57% |
| Sep 30, 2023 | -43.51% |
| Jun 30, 2023 | -53.65% |
| Mar 31, 2023 | -86.34% |
| Dec 31, 2022 | -38.83% |
| Sep 30, 2022 | -31.79% |
| Jun 30, 2022 | -32.50% |
| Mar 31, 2022 | -50.62% |
| Dec 31, 2021 | -15.65% |
| Sep 30, 2021 | -70.52% |